Christa Pike survived two doses of pentobarbital on September 30, her arms swollen and burned, her body lifting off the gurney. Tennessee Governor Bill Lee paused executions statewide and ordered a third-party review. Pike regained consciousness on October 6. Her lawyers say her veins were likely blown — the drugs never reached her bloodstream in lethal quantities. It was the second failed execution in Tennessee this year. The structural problem is not incompetence in any single case. It is a method that requires medical precision but systematically excludes medical professionals. Major medical organizations bar members from participating in executions on the grounds that it violates the mandate to do no harm. Prisons instead rely on staff with, as researchers put it, dubious credentials to perform what amounts to intravenous anesthesia on patients with degraded veins and complex health conditions. The drug supply chain compounds the fragility. Pharmaceutical companies restrict their products from execution use, forcing states to source pentobarbital and similar agents from compounding pharmacies — facilities that produce medications not manufactured commercially and not subject to the same scrutiny as mass-produced drugs. Some states stretch existing stockpiles past expiration. The combination of unregulated drugs, unqualified administrators, and medically compromised patients produces a failure mode that is predictable, not exceptional. The numbers bear this out. A survey of US executions between 1890 and 2010 found lethal injections were botched at more than twice the rate of all other methods. Since 2022 alone, Tennessee, Idaho, Alabama, Arizona, Texas, and Oklahoma have each recorded at least one botched lethal injection. In May, Tennessee called off Tony Carruthers' execution after staff struggled for over 90 minutes to establish a backup IV line. In February 2024, Idaho suspended Thomas Creech's execution after eight failed IV attempts in his arms, legs, and feet. Despite this record, lethal injection is used in 28 of 29 states that permit capital punishment. In 2025, 39 people were killed by lethal injection, compared with five by lethal gas and three by firing squad. The last electrocution was in 2020; the last hanging in the 1990s. The method's dominance is not a function of its reliability but of its aesthetics — it looks clinical, sterile, and painless to observers, even when autopsies indicate prisoners experienced pain. As law professor Corinna Barrett Lain frames it: "Lethal injection, from the very start, was about a humane-looking execution, not a humane execution." The method replaced electrocution and hanging not because it worked better but because it disturbed witnesses less. Prisoners being electrocuted sometimes caught fire. Lethal injection moved the violence behind a veneer of medical procedure, but the violence remained — it just became invisible to everyone except the person on the gurney. The Pike case forces a question states have spent decades avoiding: if the method chosen specifically because it appears humane fails this often, what does that say about the system's actual priorities? The answer, visible in every blown vein and expired drug vial and unqualified technician, is that the system optimizes for the comfort of observers, not the reliability of the process or the experience of the condemned.
